Family · Pharmaceutical analytical standards
Fenretinide
A synthetic retinoid, an analogue of vitamin A (4-HPR): it binds to retinoic acid receptors and in some tumours induces cell differentiation and death. It has been studied since the 1980s, especially for breast cancer prevention. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?One of the main trials was launched in 1987 at the National Cancer Institute in Milan, led by Umberto Veronesi, in more than 2,800 women.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
